Erythema multiforme (EM) is a rare skin condition that is characterized by an itchy rash that appears on the skin in the form of red patches, bumps, or blisters. It is usually caused by an allergic reaction to a medication or infection, but can also be caused by an autoimmune disorder. The condition can be mild or severe, and it can affect people of any age. While the rash can be painful and uncomfortable, it is usually not serious and can be treated with over-the-counter medications or topical creams. In this article, we will provide a visual guide to erythema multiforme, including what it looks like, the symptoms associated with it, and the treatment options available.
Erythema multiforme typically appears as red patches, bumps, or blisters on the skin. The rash can appear anywhere on the body, but is most commonly found on the hands, feet, and face. The rash can range in size from a few millimeters to several centimeters in diameter. It is usually symmetrical, meaning that it appears on both sides of the body. The rash is usually itchy and can be painful or tender to the touch. The rash can also have a “target” or “bull’s-eye” appearance, with a central red area surrounded by a ring of paler red. This is known as the “iris” pattern and is a characteristic of erythema multiforme. In some cases, the rash may also have a purplish or bluish hue.
In addition to the rash, erythema multiforme can also cause other symptoms, including fever, chills, sore throat, and fatigue. In some cases, the rash may be accompanied by eye irritation, such as redness, swelling, and pain. It is important to note that erythema multiforme is not contagious and cannot be spread from person to person.
Erythema multiforme is usually caused by an allergic reaction to a medication or infection. Common triggers include antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants. In some cases, the condition can be caused by an autoimmune disorder, such as lupus or Sjogren’s syndrome.
Erythema multiforme is usually diagnosed based on the appearance of the rash. Your doctor may also take a skin sample (biopsy) to confirm the diagnosis. In some cases, blood tests may be used to rule out other conditions that may be causing the rash.
The treatment of erythema multiforme depends on the severity of the condition. Mild cases may be treated with over-the-counter medications, such as antihistamines, or topical creams. In more severe cases, your doctor may prescribe oral steroids or other medications to reduce inflammation and itching.
Erythema multiforme is a rare skin condition that is characterized by an itchy rash that appears on the skin in the form of red patches, bumps, or blisters. It is usually caused by an allergic reaction to a medication or infection, but can also be caused by an autoimmune disorder. While the rash can be painful and uncomfortable, it is usually not serious and can be treated with over-the-counter medications or topical creams. This article provided a visual guide to erythema multiforme, including what it looks like, the symptoms associated with it, and the treatment options available.
1.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
2.
Dostarlimab Boosts Long-Term Survival in Endometrial Cancer
3.
Germline Profiling May Improve Risk Stratification in t-MNs
4.
Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.
5.
Scientists call into question safety of potential new anticancer treatment
1.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
2.
Gender-Specific Dual Antiplatelet Therapy Strategies for Women After PCI
3.
Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder
4.
Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance
5.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part XV
3.
Clinical Insights in Hematology
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation